NZ184722A - Pharmaceutical compositions with controlled release of active agent in the intestinal tract - Google Patents

Pharmaceutical compositions with controlled release of active agent in the intestinal tract

Info

Publication number
NZ184722A
NZ184722A NZ184722A NZ18472277A NZ184722A NZ 184722 A NZ184722 A NZ 184722A NZ 184722 A NZ184722 A NZ 184722A NZ 18472277 A NZ18472277 A NZ 18472277A NZ 184722 A NZ184722 A NZ 184722A
Authority
NZ
New Zealand
Prior art keywords
pharmaceutical compositions
active agent
controlled release
intestinal tract
intestinal
Prior art date
Application number
NZ184722A
Other languages
English (en)
Inventor
D Hazler
J-P Nougaret
J A Hersey
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of NZ184722A publication Critical patent/NZ184722A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ184722A 1976-07-27 1977-07-25 Pharmaceutical compositions with controlled release of active agent in the intestinal tract NZ184722A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH958876 1976-07-27

Publications (1)

Publication Number Publication Date
NZ184722A true NZ184722A (en) 1980-10-24

Family

ID=4353539

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ184722A NZ184722A (en) 1976-07-27 1977-07-25 Pharmaceutical compositions with controlled release of active agent in the intestinal tract

Country Status (27)

Country Link
JP (1) JPS5315411A (xx)
AR (1) AR216479A1 (xx)
AT (1) AT369987B (xx)
AU (1) AU515738B2 (xx)
BE (1) BE857122A (xx)
CA (1) CA1095833A (xx)
CY (1) CY1261A (xx)
DE (1) DE2732335C2 (xx)
DK (1) DK325677A (xx)
ES (1) ES461020A1 (xx)
FI (1) FI772217A (xx)
FR (1) FR2359607A1 (xx)
GB (1) GB1589982A (xx)
GR (1) GR65014B (xx)
HK (1) HK81884A (xx)
HU (1) HU178340B (xx)
IE (1) IE45534B1 (xx)
IL (1) IL52587A (xx)
KE (1) KE3441A (xx)
MY (1) MY8400057A (xx)
NL (1) NL176227C (xx)
NO (1) NO149874C (xx)
NZ (1) NZ184722A (xx)
PT (1) PT66850B (xx)
SE (1) SE437469B (xx)
SG (1) SG53884G (xx)
ZA (1) ZA774536B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH649216A5 (de) * 1979-08-16 1985-05-15 Sandoz Ag Verfahren zur auftragung eines magensaftresistenten filmes auf einen heilmittelkern und feste einheitsdosierungsform mit magensaftresistentem film.
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
JPS5748908A (en) * 1980-09-08 1982-03-20 Kyorin Pharmaceut Co Ltd Prolonged release type nicomol pharmaceutical
US4795327A (en) * 1984-03-26 1989-01-03 Forest Laboratories, Inc. Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
US4540566A (en) * 1984-04-02 1985-09-10 Forest Laboratories, Inc. Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
JPS61254522A (ja) * 1985-05-02 1986-11-12 Takada Seiyaku Kk 錠剤組成物
JPS62246512A (ja) * 1986-04-18 1987-10-27 Fujisawa Pharmaceut Co Ltd 反復作用製剤
GB9714675D0 (en) * 1997-07-11 1997-09-17 Smithkline Beecham Plc Novel composition
DE19959419A1 (de) 1999-12-09 2001-06-21 Ratiopharm Gmbh Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
US20030113366A1 (en) * 2001-12-14 2003-06-19 Macgregor Alexander Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3148124A (en) * 1962-06-12 1964-09-08 William E Gaunt Method of preparing sustained release pharmaceutical tablets
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
GB1301849A (xx) * 1969-12-15 1973-01-04
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions

Also Published As

Publication number Publication date
SE437469B (sv) 1985-03-04
CA1095833A (en) 1981-02-17
NL176227C (nl) 1985-03-18
FR2359607B1 (xx) 1980-02-22
NO149874B (no) 1984-04-02
KE3441A (en) 1984-09-14
PT66850A (fr) 1977-08-01
AU2730177A (en) 1979-02-01
ATA541377A (de) 1982-07-15
DK325677A (da) 1978-01-28
GB1589982A (en) 1981-05-20
BE857122A (fr) 1978-01-25
FI772217A (xx) 1978-01-28
PT66850B (fr) 1979-03-13
HK81884A (en) 1984-11-25
NO149874C (no) 1984-07-11
AU515738B2 (en) 1981-04-30
ES461020A1 (es) 1979-05-01
DE2732335A1 (de) 1978-02-02
DK325877A (da) 1978-01-20
NO772575L (no) 1978-01-30
MY8400057A (en) 1984-12-31
IL52587A0 (en) 1977-10-31
FR2359607A1 (fr) 1978-02-24
DE2732335C2 (de) 1983-01-20
NL176227B (nl) 1984-10-16
AT369987B (de) 1983-02-25
IE45534B1 (en) 1982-09-22
ZA774536B (en) 1979-02-28
SG53884G (en) 1985-03-08
IL52587A (en) 1980-09-16
HU178340B (en) 1982-04-28
IE45534L (en) 1978-01-27
AR216479A1 (es) 1979-12-28
NL7708162A (nl) 1978-01-31
JPS5315411A (en) 1978-02-13
GR65014B (en) 1980-06-13
JPS5726650B2 (xx) 1982-06-05
SE7708265L (sv) 1978-01-28
CY1261A (en) 1984-11-23

Similar Documents

Publication Publication Date Title
GR61176B (en) Pharmaceutical compositions and process for the preparation thereof
IL52081A (en) Pharmaceutical compositions for barium opacification of the digestive tract and process for preparing them
NZ183150A (en) 7-aminothiazolyl-iminoa-cetamido-cephalosporin derivatives and pharmaceutical compositions
GB2010840B (en) Cephalosporanic acid derivatives processes for the preparation thereof and pharmaceutical composition comprising the same
NZ184722A (en) Pharmaceutical compositions with controlled release of active agent in the intestinal tract
JPS5386038A (en) Pharmaceutical composition for animal and application
ZA786548B (en) Adamantylmethyl hydrazines,their preparation and pharmaceutical compositions containing them
NZ184288A (en) Ceutical compositions 10,19-dihydro-vitamin d derivatives preparation and pharma
NZ186119A (en) 7-alkoxycarbonyl-6-alkyl/halo-17-hydoxy-3-oxo-17 -pregn-4-ene-21-carboxylic acid derivatives and pharmaceutical compositions
NZ184755A (en) 2-benzylpyrrolidine derivatives and pharmaceutical compositions
NZ182591A (en) 14-substituted-daunorubicins and pharmaceutical compositions
JPS5362834A (en) Pharmaceutical composition and use thereof
JPS5369822A (en) Pharmaceutical agent
NZ185642A (en) Morphanthridine derivatives and pharmaceutical compositions
NZ182581A (en) -amino-ketones and pharmaceutical compositions
NZ181864A (en) Noroxymorphones and pharmaceutical compositions
CS186242B2 (en) Acaricide agent and mode of manufacture of active substances
NZ184103A (en) Fenzodioxole derivatives and pharmaceutical compositions
NZ184858A (en) Behenic acid esters and pharmaceutical compositions
NZ185296A (en) Corticoids and pharmaceutical compositions
PH12590A (en) 4a-aryl octahydro-1h-2-pyrindines and pharmaceutical composition thereof
NZ186059A (en) 3-sulphamoyl-5-pyrrolylal-kylbenzoic acid derivatives and pharmaceutical compositions
JPS5257310A (en) Antiihemophilia agent and preparation thereof
JPS52128364A (en) Novel corticoid * preparation thereof and antiiinflamatory pharmaceutical agent containing the same
IL53552A (en) 1-piperazinopropanol esters,their preparation and pharmaceutical compositions containing them